z-logo
open-access-imgOpen Access
HDAC2/3 inhibitor MI192 mitigates oligodendrocyte loss and reduces microglial activation upon injury: a potential role of epigenetics
Author(s) -
Mohamed A. Al-Griw,
Mansur E Shmela,
Mohamed Elhensheri,
Emad M Bennour
Publication year - 2021
Publication title -
open veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.39
H-Index - 10
eISSN - 2226-4485
pISSN - 2218-6050
DOI - 10.5455/ovj.2021.v11.i3.18
Subject(s) - microglia , histone deacetylase 2 , oligodendrocyte , epigenetics , white matter , traumatic brain injury , histone deacetylase inhibitor , medicine , apoptosis , pharmacology , histone deacetylase , pathology , biology , neuroscience , histone , myelin , central nervous system , inflammation , biochemistry , radiology , psychiatry , magnetic resonance imaging , gene
During development, oligodendrocyte (OL) lineage cells are susceptible to injury, leading to life-long clinical neurodevelopmental deficits, which lack effective treatments. Drugs targeting epigenetic modifications that inhibit histone deacetylases (HDACs) protect from many clinical neurodegenerative disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here